Name: Nautilus Biotechnology, Inc. (NAUT) Balance Sheet
Creator: FinSpry

Nautilus Biotechnology Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Nautilus Biotechnology, Inc. (NAUT) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	27.65	19.40	114.52	345.73	36.61
Short-Term Investments	102.25	154.02	69.95	160.11	40.14
Cash & Short-Term Investments	129.89	173.42	184.47	345.73	76.74
Accounts Receivable	0.00	23.28	0.00	0.00	0.00
Inventory	0.00	46.60	0.00	0.00	0.00
Other Current Assets	2.93	3.42	2.74	0.84	0.92
Total Current Assets	132.83	176.84	187.21	349.22	77.66
Non-Current Assets
Property, Plant & Equipment (Net)	32.33	36.90	32.57	31.86	6.21
Long-Term Investments	76.41	90.65	129.17	16.37	0.00
Other Non-Current Assets	1.18	1.18	1.11	1.00	0.93
Total Non-Current Assets	109.92	128.73	162.84	49.23	0.00
Total Assets	242.74	305.57	350.05	398.45	85.01
Current Liabilities
Accounts Payable	0.99	1.64	1.27	1.72	0.47
Short-Term Debt	4.10	0.00	0.00	0.00	0.00
Accrued Liabilities	0.69	3.57	1.42	1.27	0.94
Other Current Liabilities	0.52	0.38	0.44	3.12	0.13
Total Current Liabilities	7.63	9.12	6.79	5.81	3.02
Non-Current Liabilities
Long-Term Debt	26.38	31.09	28.34	29.06	0.00
Other Non-Current Liabilities	0.00	1.98	0.00	0.00	0.00
Total Non-Current Liabilities	26.38	31.09	28.34	29.06	0.00
Total Liabilities	34.01	40.21	35.13	34.87	6.31
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01	0.00
Retained Earnings	-273.02	-202.24	-138.56	-80.82	-30.33
Accumulated Other Comprehensive Income	0.06	-0.26	-1.85	-0.18	0.00
Additional Paid-in Capital	481.68	467.83	455.33	444.39	0.00
Shares Outstanding	126.11	125.07	124.87	124.30	0.00
Total Stockholders' Equity	208.73	265.35	314.92	363.58	78.70
Total Liabilities & Equity	242.74	305.57	350.05	398.45	0.00